Corpus ID: 29145964

PHARMACOPHORE MODELING AND QSAR STUDY OF THIENO (3, 2 - b) PYRIMIDINE ANALOGS AS VEGFR-2 INHIBITORS Original Article

@inproceedings{Prabhu2014PHARMACOPHOREMA,
  title={PHARMACOPHORE MODELING AND QSAR STUDY OF THIENO (3, 2 - b) PYRIMIDINE ANALOGS AS VEGFR-2 INHIBITORS Original Article},
  author={K. Prabhu and M. Kumar and V. Gopalakrishnan},
  year={2014}
}
  • K. Prabhu, M. Kumar, V. Gopalakrishnan
  • Published 2014
  • Chemistry
  • Objective: Vascular endothelial growth factor (VEGF) and its receptor tyrosine kinase VEGFR-2 are critical regulators for the activation of angiogenesis and tumor progression. Thus the VEGFR-2 inhibition represents an attractive target for drug discovery in most of the cancers. To know the structural requirements that will lead to enhanced inhibitory activities, the 3D-QSAR (quantitative structure-activity relationship) studies were performed on series of thieno [3, 2 - b] pyrimidine molecules… CONTINUE READING

    Figures and Tables from this paper

    References

    SHOWING 1-10 OF 22 REFERENCES
    Pharmacophore based 3D-QSAR modeling and free energy analysis of VEGFR-2 inhibitors
    • 4
    Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases.
    • 48
    A network-QSAR model for prediction of genetic-component biomarkers in human colorectal cancer.
    • 52
    • PDF
    Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
    • 2,151
    • PDF
    Vascular Endothelial Growth Factor Mediates Intracrine Survival in Human Breast Carcinoma Cells through Internally Expressed VEGFR1/FLT1
    • 247
    • PDF
    VEGFR‐2 expression in carcinoid cancer cells and its role in tumor growth and metastasis
    • 55
    Molecular mechanisms and clinical applications of angiogenesis
    • 3,508